Lanso 30 Capsule
by Square Pharmaceuticals Limited
৳6.04
GENERAL Pharmaceuticals Ltd.
Lansoprazole
Lansoprazole is used to treat active duodenal ulcers in the short term.
Lansoprazole may be a substituted benzimidazole, and is additionally known as PPI due to its property to piece the ultimate step of corrosive discharge by repressing H+/K+ ATPase chemical framework in gastric parietal cell. Both basal and fortified corrosive are inhibited.
Lansoprazole appears to be a selective inhibitor of the cytochrome P-450 monooxygenase system; it may affect hepatic clearance, although no clinically meaningful interactions have been reported to far. The effect of Lansoprazole on the oral combination contraceptive pill is still unknown. A more thorough investigation is presently ongoing. The drop in gastric acid is anticipated to alter bacterial colonization of the stomach and duodenum, as well as vitamin B12 absorption, resulting in physiological effects similar to those seen with Omeprazole.
Patients with known hypersensitivity to any component of the formulation should avoid using lansoprazole.
Severe or irreversible side effects include the possibility of carcinoid tumors being induced by severe acid suppression, as well as a rise in serum gastrin. Serum gastrin levels rise over the first three months of treatment and subsequently remain stable, though at a lower level than in pernicious anemia. In patients with Helicobacter pylori infection, long-term treatment with a proton pump inhibitor may hasten the onset of atrophic gastritis.
Symptomatic side effect: At 30 mg per day, the incidence of dose-dependent diarrhoea is around 4%, rising to 8% at 60 mg per day. Headache affects 2% to 3% of people who are being treated.
Lansoprazole ought to be dodged in pregnancy unless there are compelling reasons.
Malignancy of the stomach should be ruled out. Hepatic dysfunction. Lactation and pregnancy.
Proton Pump Inhibitor.
Store at 25° C.
General Pharmaceuticals Ltd.
by The IBN SINA Pharmaceutical Industry Ltd.
৳6.00